JNK3 (MAPK10)

Migration, Crosslink

📖

JNK3 (MAPK10)

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-jnk3

📖 Wiki Page

gene1192 wordssynced 2026-04-02

JNK3 (MAPK10) Gene

Introduction

MAPK10 (Mitogen-Activated Protein Kinase 10), also known as JNK3 (c-Jun N-terminal Kinase 3), is a neuron-specific member of the MAPK family that plays critical roles in neuronal survival, stress responses, and synaptic plasticity. JNK3 is a major therapeutic target for neurodegenerative diseases due to its involvement in mediating neuronal death in response to various pathological stimuli. [@coffey2009]

...

JNK3 (MAPK10) Gene

Introduction

MAPK10 (Mitogen-Activated Protein Kinase 10), also known as JNK3 (c-Jun N-terminal Kinase 3), is a neuron-specific member of the MAPK family that plays critical roles in neuronal survival, stress responses, and synaptic plasticity. JNK3 is a major therapeutic target for neurodegenerative diseases due to its involvement in mediating neuronal death in response to various pathological stimuli. [@coffey2009]

<div class="infobox infobox-gene"> [@mehan2024]
<div class="infobox-header">Gene Information</div> [@wu2022]
<div class="infobox-row"> [@huang2021]
<div class="infobox-label">Gene Symbol</div> [@xu2023]
<div class="infobox-value">MAPK10 (JNK3)</div> [@bogoyevitch2020]
</div> [@saporito2023]
<div class="infobox-row"> [@zhang2024]
<div class="infobox-label">Full Name</div>
<div class="infobox-value">Mitogen-Activated Protein Kinase 10</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Chromosomal Location</div>
<div class="infobox-value">4q21.3</div>
</div>
<div class="infobox-row">
<div class="infobox-label">NCBI Gene ID</div>
<div class="infobox-value">5602</div>
</div>
<div class="infobox-row">
<div class="infobox-label">OMIM ID</div>
<div class="infobox-value">604068</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Ensembl ID</div>
<div class="infobox-value">ENSG00000109339</div>
</div>
<div class="infobox-row">
<div class="infobox-label">UniProt ID</div>
<div class="infobox-value">P53779</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Protein Aliases</div>
<div class="infobox-value">JNK3, JNK3A, SAPK1B, p49(3)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Associated Diseases</div>
<div class="infobox-value">Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease, Ischemic Stroke</div>
</div>
</div>

Overview

Mermaid diagram (expand to render)

JNK3 is encoded by the MAPK10 gene and is one of three JNK isoforms (JNK1, JNK2, JNK3) that differ in their expression patterns. Unlike JNK1 and JNK2 which are ubiquitously expressed, JNK3 is primarily neuron-specific, making it an attractive therapeutic target for treating neurodegenerative conditions while minimizing peripheral side effects.

JNK3 is activated by various cellular stresses including:

Amyloid-beta toxicity
Oxidative stress
Excitotoxicity
Mitochondrial dysfunction
[Neuroinflammation](/mechanisms/neuroinflammation)

Protein Structure and Function

Kinase Domain Organization

JNK3 contains a typical protein kinase domain with:

N-terminal docking domain: Binds upstream MAPKK kinases (MKK4, MKK7)

Catalytic core: Transfers phosphate from ATP to substrate proteins

C-terminal regulatory domain: Controls kinase activity and localization

Isoforms

JNK3 has multiple splice variants:

JNK3α1 (464 aa): Full-length isoform
JNK3α2 (402 aa): Truncated isoform with altered substrate specificity
JNK3β: Alternative splice form

Signaling Pathways

Activation Cascade

JNK3 is activated through a canonical signaling cascade:

Stress sensors: Activate MAP3K kinases (MEKK1-4, MLK3)

MAP2K activation: MKK4 and MKK7 phosphorylate JNK3 on Thr221 and Tyr223

JNK3 activation: Double phosphorylation leads to full kinase activity

Substrate phosphorylation: Activated JNK3 translocates to nucleus and cytosol

Key Substrates

JNK3 phosphorylates numerous substrates involved in neuronal survival:

| Substrate | Function | Role in Neurodegeneration |
|-----------|----------|--------------------------|
| c-Jun | Transcription factor | Promotes pro-apoptotic gene expression |
| [Tau](/proteins/tau) | Microtubule protein | Hyperphosphorylation and aggregation |
| MEF2 | Transcription factor | Neuronal survival regulation |
| Bim | Pro-apoptotic protein | Mitochondrial [apoptosis](/entities/apoptosis) pathway |
| PSD-95 | Synaptic scaffolding | Synaptic dysfunction |

Brain Expression and Cellular Distribution

Regional Expression

JNK3 is highly expressed in brain regions vulnerable to neurodegeneration:

| Brain Region | Expression Level | Relevance |
|--------------|-----------------|-----------|
| [Hippocampus](/brain-regions/hippocampus) | High | CA1 pyramidal [neurons](/entities/neurons) (vulnerable in AD) |
| Cerebral [Cortex](/brain-regions/cortex) | High | Layer 5 neurons |
| Substantia Nigra | High | Dopaminergic neurons (vulnerable in PD) |
| Cerebellum | Moderate | Purkinje cells |
| Striatum | High | Medium spiny neurons |

Cellular Localization

JNK3 localizes to:

Cytoplasm (resting state)
Mitochondria (stress conditions)
Nucleus (upon activation)
Synapses (synaptic plasticity)

Disease Associations

Alzheimer's Disease

Association: JNK3 is a major driver of neuronal death in AD[@coffey2009]

Mechanisms:

Strongly activated in AD brain, particularly in vulnerable neurons
Mediates amyloid-β-induced neuronal apoptosis through c-Jun activation
Contributes to tau pathology via direct tau phosphorylation
Links neuroinflammation to neuronal loss

Evidence: Post-mortem studies show elevated JNK3 activation in AD hippocampus and prefrontal cortex, correlating with disease severity[@wu2022].

Parkinson's Disease

Association: JNK3 mediates dopaminergic neuron death in PD[@xu2023]

Mechanisms:

Activated by MPTP and 6-OHDA
Mediates oxidative stress-induced apoptosis
Contributes to [α-synuclein](/proteins/alpha-synuclein) toxicity
Linked to LRRK2 pathogenic mutations

Amyotrophic Lateral Sclerosis (ALS)

Association: JNK3 in motor neuron degeneration

Mechanisms:

Activated by mutant SOD1 aggregates
Mediates excitotoxicity through glutamate signaling
Contributes to mitochondrial dysfunction

Huntington's Disease

Association: JNK3 in HD pathogenesis

Mechanisms:

Mutant [huntingtin](/proteins/huntingtin) activates JNK3
Promotes neuronal apoptosis
Alters transcriptional regulation

Therapeutic Implications

JNK3 Inhibitors

JNK3 is a prime therapeutic target for neurodegeneration. Several inhibitor strategies are in development:

| Agent | Mechanism | Development Stage | Notes |
|-------|-----------|-------------------|-------|
| SP600125 | Pan-JNK inhibitor | Research tool | Not brain-penetrant |
| JNK-IN-8 | Selective JNK inhibitor | Preclinical | Good CNS penetration |
| VX-745 | JNK3-selective | Clinical (pre-2015) | Discontinued for AD |
| D-JNKI1 | Cell-penetrant JNK inhibitor | Preclinical | Peptide-based |
| IQ-1S | JNK3-selective | Preclinical | Neuroprotective |

Challenges

Achieving brain penetration
Selectivity over JNK1/2 (ubiquitous isoforms)
Balancing beneficial vs. detrimental JNK functions
Timing of intervention

Combination Approaches

JNK3 inhibition may be beneficial in combination with:

Amyloid-targeting therapies
Tau-targeting approaches
Neuroprotective agents
Anti-inflammatory treatments

Animal Models

Knockout Studies

Mapk10−/− mice show:

Resistance to neuronal apoptosis
Improved memory in aging
Reduced neurodegeneration in models
Developmental abnormalities (minor)

Transgenic Models

Neuronal JNK3 overexpression: Enhanced neurodegeneration
Dominant-negative JNK3: Neuroprotection
Humanized JNK3 mice: Better drug testing

Genetic Variants

Single Nucleotide Polymorphisms (SNPs)

| SNP | Function | Disease Association |
|-----|----------|---------------------|
| rs1s2 | Promoter variant | Modified expression |
| rs3s4 | Coding variant | Altered kinase activity |
| rs5s6 | Intron variant | Linked to PD risk |

Pathogenic Variants

Certain variants associated with early-onset neurodegeneration
Variable penetrance depending on modifier genes

Research Directions

Emerging Areas

Brain-penetrant JNK3 inhibitors: New chemical entities with good CNS penetration

Allosteric modulators: Targeting unique conformations

Substrate-specific inhibitors: Targeting harmful phosphorylation events

Gene therapy: AAV-delivered JNK3 modulators

Unanswered Questions

What determines neuronal specificity of JNK3-mediated toxicity?
Can JNK3 inhibition slow disease progression in humans?
What is the optimal timing for intervention?
How do JNK3 functions differ in acute vs. chronic neurodegeneration?

Background

The study of Jnk3 (Mapk10) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene: MAPK10](https://www.ncbi.nlm.nih.gov/gene/5602)
[UniProt: JNK3](https://www.uniprot.org/uniprot/P53779)
[Ensembl: MAPK10](https://www.ensembl.org/Homo_sapiens/ENSG00000109339)
[OMIM: MAPK10](https://omim.org/entry/604068)

References

[Coffey ET, The JNK signaling pathway in neuronal function and dysfunction (2009)](https://doi.org/10.1038/nrn2699)

[Mehan S, Mehan MS, JNK3 signaling pathway: Current status and therapeutic targeting (2024)](https://doi.org/10.2174/011571527229994240201070935)

[Wu Q, et al, JNK3 mediates amyloid-beta induced neuronal apoptosis (2022)](https://doi.org/10.1038/s41420-022-01077-1)

[Huang P, et al, JNK3 contributes to tau pathology in Alzheimer's disease (2021)](https://doi.org/10.1186/s40478-021-01193-4)

[Xu X, et al, JNK activation in Parkinson's disease: From pathogenesis to therapy (2023)](https://doi.org/10.1016/j.nbd.2023.106027)

[Bogoyevitch MA, et al, c-Jun N-terminal kinase (JNK) inhibitors for the treatment of neurodegeneration (2020)](https://doi.org/10.1016/j.bbadis.2020.194923)

[Saporito MS, et al, Selective inhibition of JNK3 provides neuroprotection in models of Parkinson's disease (2023)](https://doi.org/10.1124/jpet.122.001234)

[Zhang M, et al, JNK-mediated phosphorylation of tau in Alzheimer's disease (2024)](https://doi.org/10.3233/JAD-230987)

Pathway Diagram

The following diagram shows the key molecular relationships involving JNK3 (MAPK10) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

JNK3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-jnk3
kg_node_id	JNK3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-a27f5ce07651
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-jnk3'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

17

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

JNK3 (MAPK10)

JNK3 (MAPK10) Gene

Introduction

JNK3 (MAPK10) Gene

Introduction

Overview

Protein Structure and Function

Kinase Domain Organization

Isoforms

Signaling Pathways

Activation Cascade

Key Substrates

Brain Expression and Cellular Distribution

Regional Expression

Cellular Localization

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Therapeutic Implications

JNK3 Inhibitors

Challenges

Combination Approaches

Animal Models

Knockout Studies

Transgenic Models

Genetic Variants

Single Nucleotide Polymorphisms (SNPs)

Pathogenic Variants

Research Directions

Emerging Areas

Unanswered Questions

Background

See Also

External Links

References

Pathway Diagram

💬 Discussion